InnerPlant roll out on course after reaching regulatory milestone

InnerPlant has successfully completed the FDA’s New Protein Consultation process for its genetically engineered soybean, InnerSoy, which emits fluorescent signals to warn farmers of fungal stress. This milestone supports the launch of its CropVoice platform, aimed at enhancing crop protection and sustainability for the 2025 growing season, marking a significant advancement in agtech innovation.

Original excerpt: InnerPlant’s innovative technology has generated significant excitement in the agtech sector. Its plans have now been buoyed after successfully completing the FDA’s New Protein Consultation…

Source: AgTechNavigator.com